James E Fickenscher Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Fickenscher.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Fickenscher. James E Fickenscher is a Senior Vice President & CFO in ANTARES PHARMA, INC. ($ATRS) and a Chief Financial Officer in AUXILIUM PHARMACEUTICALS INC ($AUXL) and a Chief Financial Officer in Zynerba Pharmaceuticals, Inc. ($ZYNE).
Address: C/O AUXILIUM PHARMACEUTICALS, INC 160 WEST GERMANTOWN PIKE NORRISTOWN 19401 PA
Companies in which James E Fickenscher is an Insider
ANTARES PHARMA, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Fickenscher: Senior Vice President & CFO
Holdings: 391,266 shares
Current Value: $860,785
Latest Transaction: Jun 06 2016
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AUXILIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Fickenscher: Chief Financial Officer
Holdings: 25,000 shares
Latest Transaction: May 20 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zynerba Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Fickenscher: Chief Financial Officer
Holdings: 72,718 shares
Current Value: $1,343,101
Latest Transaction: Jan 25 2021
$ZYNE Market Capitalization: $186.92M
$ZYNE Previous Close: $18.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James E Fickenscher
Sentiment: All, ATRS, AUXL, ZYNE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 3.58 | 78,000 | 279,240 | 78,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 52,000 | 0 | 72,718 | 20.7 K to 72.7 K (+250.99 %) |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 5.05 | 85,000 | 429,250 | 85,000 | |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 3.65 | 88,099 | 321,561 | 88,099 | |
| Aug 07 2018 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 5.97 | 8,518 | 50,842 | 20,718 | 12.2 K to 20.7 K (+69.82 %) |
| Jan 16 2018 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 11.71 | 67,500 | 790,425 | 67,500 | |
| May 16 2017 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 19.82 | 5,200 | 103,064 | 12,200 | 7 K to 12.2 K (+74.29 %) |